GlassScriptPhysician profile
Mark Warburton
NPI 1851390595
$1,706.23
in general payments reported to CMS, 2019-2025
12 companies · $235 in 2025
The $235 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $260 · 2020: $77.79 · 2021: $474 · 2022: $89.53 · 2023: $487 · 2024: $82.11 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $804.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $803.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $263.44 | 2019-2022 | |
| Axogen | $255.23 | 2020-2023 | Avance Nerve Graft |
| Endo USA, INC. | $207.12 | 2024-2025 | Xiaflex |
| Skeletal Dynamics INC | $176.21 | 2021-2023 | Align, Implate, Geminus |
| Zimmer Biomet Holdings, INC. | $125.00 | 2021 | |
| Depuy Synthes Sales INC. | $120.25 | 2023 | Vivigen Mis Delivery System, Fibergraft Aeridyan Matrix, Fibergraft Bg Morsels |
| Piedmont Plus Innovation | $117.71 | 2023 | |
| Osteocentric Technologies, INC. | $110.00 | 2025 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Endo Pharmaceuticals INC. | $101.19 | 2021 | |
| Checkpoint Surgical, INC | $80.66 | 2019 | |
| Smith+Nephew, INC. | $77.19 | 2019 | |
| Medtronic, INC. | $72.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Warburton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.